Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacologically active drugs conclusions

Drug activity related to proposed indication Secondary pharmacodynamics Pharmacology summary Pharmacology conclusions Safety pharmacology Neurological effects Cardiovascular effects Pulmonary effects Renal effects... [Pg.418]

In CONCLUSION, evidence has been presented to show that the benzodiazepines produce their variety of pharmacological effects by activating specific receptors that form part of the main inhibitory neurotransmitter receptor system, the GABA receptor, in the mammalian brain. Different classes of benzodiazepine receptor ligands have been developed which can alleviate anxiety or produce anxiety according to the fine structural changes that occur when the drugs interact with the benzodiazepine receptor. [Pg.240]

In CONCLUSION, the use of the "classical" neuroleptics, as exemplified by the phenothiazines, thioxanthines, butyrophenones and diphenylbutyl-piperidines, has been a landmark in the pharmacotherapy of schizophrenia and psychotic disorders. The efficacy of such drugs in the alleviation of the symptoms of schizophrenia is universally accepted. However, it is also evident that they have a spectrum of adverse effects that frequently renders their long-term use problematic. Side effects such as akathisia, Parkinsonism, tardive dyskinesia and the all too frequent changes in peripheral autonomic activity are largely predictable from the structure of the molecules and the basic animal pharmacology data. Such adverse effects, and the difficulties encountered when attempting to reduce their frequency and severity by concurrent medication, has stimulated the development of "atypical" neuroleptics such as clozapine and risperidone which, hopefully, will combine efficacy with a reduction in side effects. [Pg.294]

In conclusion, phosphorothioate oligonucleotides may interact with a wide range of proteins through several types of mechanisms. These interactions may influence the pharmacokinetic, pharmacologic, and toxicologic properties of these molecules. They may also complicate studies on the mechanism of action of these drugs, and may obscure an antisense activity. For example, phosphorothio-... [Pg.131]


See other pages where Pharmacologically active drugs conclusions is mentioned: [Pg.2]    [Pg.108]    [Pg.3]    [Pg.642]    [Pg.235]    [Pg.431]    [Pg.457]    [Pg.311]    [Pg.7]    [Pg.216]    [Pg.62]    [Pg.237]    [Pg.157]    [Pg.74]    [Pg.252]    [Pg.201]    [Pg.76]    [Pg.7]    [Pg.252]    [Pg.478]    [Pg.642]    [Pg.720]    [Pg.157]    [Pg.121]    [Pg.221]    [Pg.209]    [Pg.300]    [Pg.9]    [Pg.121]    [Pg.474]    [Pg.181]    [Pg.166]    [Pg.211]    [Pg.303]    [Pg.288]    [Pg.150]    [Pg.221]    [Pg.507]    [Pg.257]    [Pg.2]    [Pg.159]    [Pg.351]    [Pg.185]    [Pg.591]    [Pg.147]   
See also in sourсe #XX -- [ Pg.2 , Pg.199 , Pg.202 ]




SEARCH



Active drug

Conclusion

Drugs activity

Pharmacologic activity

Pharmacologically active

Pharmacology activity

© 2024 chempedia.info